Roche Gets Food and Drug Administration OK for Improved HIV Test
April 11, 2003
Swiss manufacturer Roche Holding AG said Friday the US Food and Drug Administration has cleared an improved test to measure viral levels in the blood of HIV/AIDS patients. The test is designed to amplify and detect genetic material, allowing for the accurate measurement of even small amounts of virus. "The Cobas Amplicor HIV-1 Monitor Test (version 1.5) will allow laboratories to delivery quality HIV viral load tests in a shorter time, thanks to cutting edge automation," said Heino von Prondzynski, head of Roche Diagnostics.
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.